Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT01194414

Public ClinicalTrials.gov record NCT01194414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel Group Study of the Safety and Effect on Clinical Outcome of Tocilizumab SC Versus Tocilizumab IV, in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs), in Patients With Moderate to Severe Active Rheumatoid Arthritis

Study identification

NCT ID
NCT01194414
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,262 participants

Conditions and interventions

Interventions

  • Disease-modifying antirheumatic drugs (DMARDs) Drug
  • placebo to tocilizumab IV Drug
  • placebo to tocilizumab SC Drug
  • tocilizumab IV Drug
  • tocilizumab SC Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2010
Primary completion
Dec 31, 2011
Completion
Jul 31, 2013
Last update posted
Jun 19, 2016

2010 – 2013

United States locations

U.S. sites
54
U.S. states
25
U.S. cities
51
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801
Not listed Tuscaloosa Alabama 35406
Not listed Tucson Arizona 85704
Not listed Tucson Arizona 85712
Not listed Long Beach California 90806
Not listed Los Angeles California 90048
Not listed Upland California 91786
Not listed Van Nuys California 91405
Not listed Denver Colorado 80230-7127
Not listed Bridgeport Connecticut 06606
Not listed Delray Beach Florida 33484
Not listed Miami Florida 33133
Not listed Ocala Florida 34474
Not listed Orlando Florida 32806
Not listed Palm Harbor Florida 34684
Not listed Pinellas Park Florida 33782
Not listed South Miami Florida 33143
Not listed Tampa Florida 33614
Not listed Coeur d'Alene Idaho 83814
Not listed Morton Grove Illinois 60053
Not listed Wichita Kansas 67208
Not listed Monroe Louisiana 71203
Not listed Petoskey Michigan 49770
Not listed Saint Claire Shores Michigan 48081
Not listed Eagan Minnesota 55121
Not listed Florissant Missouri 63031
Not listed St Louis Missouri 63117
Not listed St Louis Missouri 63131
Not listed Lebanon New Hampshire 03756
Not listed Clifton New Jersey 07012
Not listed Manalapan New Jersey 07726
Not listed Voorhees Township New Jersey 08043
Not listed Albuquerque New Mexico 87102
Not listed Albany New York 12206
Not listed Binghamton New York 13905
Not listed Orchard Park New York 14127
Not listed Asheville North Carolina 28803
Not listed Raleigh North Carolina 27609
Not listed Wilmington North Carolina 28401
Not listed Cincinnati Ohio 45219
Not listed Toledo Ohio 43623
Not listed Oklahoma City Oklahoma 73103
Not listed Tulsa Oklahoma 74135
Not listed Bethlehem Pennsylvania 18015
Not listed Charleston South Carolina 29406
Not listed Charleston South Carolina 29407
Not listed Knoxville Tennessee 37909
Not listed Memphis Tennessee 38119
Not listed Houston Texas 77004
Not listed San Antonio Texas 78217
Not listed Olympia Washington 98502
Not listed Seattle Washington 98122
Not listed Spokane Washington 99204
Not listed Wenatchee Washington 98801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 162 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01194414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 19, 2016 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01194414 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →